OVERDOSAGE
In clinical trials of THYROGEN, three patients experienced
symptoms after receiving THYROGEN doses higher than those
recommended. Two patients had nausea after a 2.7 mg IM dose (3
times the recommended dose), and in one of these patients, the event was
accompanied by weakness, dizziness and headache. Another patient
experienced nausea, vomiting and hot flashes after a 3.6 mg IM dose (4
times the recommended dose). There is no specific therapy for
THYROGEN overdose. Supportive care is
recommended.
|